Allogeneic hematopoietic stem cell transplantation for aplastic anemia using low-dose anti-thymocyte globuli
Phase 2
- Conditions
- SAA
- Registration Number
- JPRN-UMIN000006071
- Lead Sponsor
- Kanto Study Group for Cell Therapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria 1. Patients with poorly controlled DM 2. Patients with poorly controlled hypertension 3. Patients with poorly controlled active infection 4. Patients with chromosome 7 abnormality 5. Patients with coexistence of malignancy 6. Patients who are pregnant or nursing 7. Patients with serious mental disorder 8. Patients with HBs antigen or HBe antigen positive 9. Patients with HIV antibody positive 10. Patients who are allergic to drugs used in conditioning regimen 11. Patients who had undergone allogeneic HSCT
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method